MARKET

ANAB

ANAB

Anaptysbio Inc
NASDAQ
48.77
+0.39
+0.81%
Pre Market: 49.20 +0.43 +0.88% 08:27 11/12 EST
OPEN
49.00
PREV CLOSE
48.38
HIGH
49.16
LOW
47.81
VOLUME
748
TURNOVER
0
52 WEEK HIGH
76.99
52 WEEK LOW
31.79
MARKET CAP
1.46B
P/E (TTM)
-60.5312
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ANAB last week (1102-1106)?
Weekly Report · 3d ago
Weekly Report: what happened at ANAB last week (1026-1030)?
Weekly Report · 11/02 09:56
Riverwater Micro Opportunities Strategy Q3 2026 Portfolio Activity
Seeking Alpha · 10/30 09:55
Did Rectal Cancer Approval Just Shift AnaptysBio's (ANAB) Investment Narrative?
Simply Wall St · 10/29 21:50
Diamond Hill Small-Mid Cap Fund Q3 2026 Contributors And Detractors
Seeking Alpha · 10/29 07:50
AnaptysBio (ANAB) Gains From Jemperli Approval, Is The Royalty Upside Already Priced In?
Simply Wall St · 10/27 13:25
Analysts Offer Insights on Healthcare Companies: AnaptysBio (ANAB), Bristol-Myers Squibb (BMY) and Parabilis Medicines, Inc. (PBLS)
TipRanks · 10/26 14:50
Weekly Report: what happened at ANAB last week (1019-1023)?
Weekly Report · 10/26 09:56
More
About ANAB
AnaptysBio, Inc. is a royalty management company. The Company manages the financial collaborations for Jemperli with GlaxoSmithKline (GSK) and imsidolimab with Vanda Pharmaceuticals Inc. (Vanda). The Company's financial collaboration with GSK is focused upon the development and commercialization of Anaptys-discovered Jemperli (dostarlimab), a PD-1 antagonist, approved for endometrial cancer and dMMR pan tumors, and is being studied in rectal cancer, colon cancer and head and neck squamous cell carcinoma. The Company's financial collaboration with Vanda is focused upon the development and commercialization of Anaptys-discovered imsidolimab, an IL-36R antagonist, which is being developed for generalized pustular psoriasis (GPP).

Webull offers AnaptysBio Inc stock information, including NASDAQ: ANAB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ANAB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ANAB stock methods without spending real money on the virtual paper trading platform.